MedPath

eech Therapy In Eczema.

Phase 2
Conditions
Health Condition 1: L209- Atopic dermatitis, unspecified
Registration Number
CTRI/2020/05/025282
Lead Sponsor
ttarakhand Ayurveda University Gurukul Campus Haridwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients will be diagnosed on the basis of classical signs and symptoms of vicharchika.

Exclusion Criteria

1.Patients suffering from hepatitis B , HIV , Tuberculosis , Diabetes.

2.Patients suffering from other major medical and psychiatric disorders.

3.Pregnant and lactating women.

4.Patients from age group below 16 and above 60 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of therapy , objectively all signs and symptoms were given scoring depending upon their severity: <br/ ><br>1. complete relief - 100% relief <br/ ><br>2. Marked improvement - 76% to 99% relief <br/ ><br>3. Moderate improvement - 51% to 75% relief <br/ ><br>4. Mild improvement - 26% to 50% relief <br/ ><br>5. No improvement- 0% to 25% reliefTimepoint: 1. Patients will be given two sitting in a <br/ ><br> week with total eight sitting in four <br/ ><br> weekend. <br/ ><br>2. assessment will be done on 30th day.
Secondary Outcome Measures
NameTimeMethod
Exacerbation in signs and symptonsTimepoint: one month
© Copyright 2025. All Rights Reserved by MedPath